%Responders to NATALIZUMAB in the cohort (WORLD):
by Thymidine Incorporation (95% CI): %61.0329 (56.338,65.7277)
by IL-2 ELISpot (95% CI): %7.277 (4.9296,9.8592)
by Combined Thymidine Incorporation & IL-2 ELISpot (95% CI): %7.0423 (4.6948,9.6244)
--
%Similarity between Thymidine Incorporation & IL-2 ELISpot predictions (95% CI): %45.6831 (40.9684,50.3978)
